Invention Grant
- Patent Title: Survival predictor for diffuse large B cell lymphoma
-
Application No.: US14540302Application Date: 2014-11-13
-
Publication No.: US09970059B2Publication Date: 2018-05-15
- Inventor: Lisa Rimsza , Andrew T. Lister , Wing C. Chan , Dennis Weisenburger , Jan Delabie , Erlend B. Smeland , Harald Holte , Stein Kvaloy , Rita M. Braziel , Richard I. Fisher , Pedro Jares , Armando Lopez-Guillermo , Elias Campo Guerri , Elaine S. Jaffe , Georg Lenz , Wyndham H. Wilson , George Wright , Sandeep S. Dave , Louis M. Staudt , Randy D. Gascoyne , Joseph M. Connors , Hans-Konrad Muller-Hermelink , Andreas Rosenwald , German Ott
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services , Arizona Board of Regents on behalf of the University of Arizona , Queen Mary University of London , Board of Regents of the University of Nebraska , Oslo University Hospital HF , Oregon Health & Science University , University of Rochester , Hospital Clinic de Barcelona , Universitat De Barcelona , British Columbia Cancer Agency Branch , Julius-Maximilians-University of Wuerzburg
- Applicant Address: US DC Washington US AZ Tucson GB London US NE Lincoln NO Oslo US OR Portland US NY Rochester ES Barcelona ES Barcelona CA Vancouver DE Würzburg
- Assignee: The United States of America, as represented by the Secretary, Department of Human Services,Arizona Board of Regents on behalf of the University of Arizona,Queen Mary University of London,Board of Regents of the University of Nebraska,Oslo University Hospital HF,Oregon Health & Science University,University of Rochester,Hospital Clinic de Barcelona,Universitat de Barcelona,British Columbia Cancer Agency Branch,Julius-Maximilians-University of Würzburg
- Current Assignee: The United States of America, as represented by the Secretary, Department of Human Services,Arizona Board of Regents on behalf of the University of Arizona,Queen Mary University of London,Board of Regents of the University of Nebraska,Oslo University Hospital HF,Oregon Health & Science University,University of Rochester,Hospital Clinic de Barcelona,Universitat de Barcelona,British Columbia Cancer Agency Branch,Julius-Maximilians-University of Würzburg
- Current Assignee Address: US DC Washington US AZ Tucson GB London US NE Lincoln NO Oslo US OR Portland US NY Rochester ES Barcelona ES Barcelona CA Vancouver DE Würzburg
- Agency: Leydig, Voit & Mayer, Ltd.
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574
Abstract:
The invention provides methods and materials related to a gene expression-based survival predictor for DLBCL patients.
Public/Granted literature
- US20150132297A1 SURVIVAL PREDICTOR FOR DIFFUSE LARGE B CELL LYMPHOMA Public/Granted day:2015-05-14
Information query
